Longitudinal molecular trajectories of diffuse glioma in adults.

Autor: Barthel FP; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Pathology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Johnson KC; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Varn FS; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Moskalik AD; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Tanner G; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Kocakavuk E; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; DKFZ Division of Translational Neurooncology at the West German Cancer Center, German Cancer Consortium Partner Site, University Hospital Essen, Essen, Germany.; Department of Neurosurgery, University Hospital Essen, Essen, Germany., Anderson KJ; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Abiola O; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Alfaro KD; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alpar D; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Amin SB; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Ashley DM; Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, USA., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Cambridge, MA, USA., Barnholtz-Sloan JS; Department of Population and Quantitative Health Sciences, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Beroukhim R; Broad Institute, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Brastianos PK; Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA., Brat DJ; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Brodbelt AR; Department of Neurosurgery, University of Liverpool & Walton Centre NHS Trust, Liverpool, UK., Bruns AF; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Bulsara KR; Division of Neurosurgery, The University of Connecticut Health Center, Farmington, CT, USA., Chakrabarty A; Department of Cellular and Molecular Pathology, Leeds Teaching Hospital NHS Trust, St James's University Hospital, Leeds, UK., Chakravarti A; Department of Radiation Oncology, The Ohio State Comprehensive Cancer Center-Arthur G. James Cancer Hospital, Columbus, OH, USA., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT, USA., Claus EB; Yale University School of Public Health, New Haven, CT, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Cochran EJ; Department of Pathology & Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Connelly J; Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA., Costello JF; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., Finocchiaro G; Fondazione IRCCS Istituto Neurologico Besta, Milano, Italy., Fletcher MN; Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany., French PJ; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands., Gan HK; Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Gilbert MR; Neuro-Oncology Branch, National Institutes of Health, Bethesda, MD, USA., Gould PV; Anatomic Pathology Service, Hôpital de l'Enfant-Jésus, CHU de Québec-Université Laval, Quebec, Quebec, Canada., Grimmer MR; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., Iavarone A; Department of Neurology, Columbia University Medical Center, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.; Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA., Ismail A; Department of Cellular and Molecular Pathology, Leeds Teaching Hospital NHS Trust, St James's University Hospital, Leeds, UK., Jenkinson MD; Department of Neurosurgery, University of Liverpool & Walton Centre NHS Trust, Liverpool, UK., Khasraw M; Cooperative Trials Group for Neuro-Oncology (COGNO) NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Kim H; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Kouwenhoven MCM; Department of Neurology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., LaViolette PS; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA., Li M; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Lichter P; Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ligon KL; Broad Institute, Cambridge, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Lowman AK; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA., Malta TM; Department of Neurosurgery, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA., Mazor T; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., McDonald KL; Cure Brain Cancer Biomarkers and Translational Research Group, Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Molinaro AM; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA., Nam DH; Department of Neurosurgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, South Korea., Nayyar N; Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA., Ng HK; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong., Ngan CY; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Niclou SP; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Niers JM; Department of Neurology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Noushmehr H; Department of Neurosurgery, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA., Noorbakhsh J; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Ormond DR; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA., Park CK; Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea., Poisson LM; Department of Public Health Sciences, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA., Rabadan R; Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.; Department of Systems Biology, Columbia University, New York, NY, USA., Radlwimmer B; Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rao G; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reifenberger G; Institute of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Sa JK; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, South Korea., Schuster M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Shaw BL; Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA., Short SC; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Smitt PAS; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands., Sloan AE; Department of Neurological Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.; Department of Neurosurgery, Case Western Reserve University, Cleveland, OH, USA.; Seidman Cancer Center and Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands., Suzuki H; The Hospital for Sick Children, Toronto, ON, Canada., Tabatabai G; Interdiscplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, DKTK Partner Site Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Van Meir EG; Department of Neurosurgery, School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, USA., Watts C; Institute of Cancer Genome Sciences, Department of Neurosurgery, University of Birmingham, Birmingham, UK., Weller M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Wesseling P; Department of Pathology, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Westerman BA; Department of Neurosurgery, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Widhalm G; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria., Woehrer A; Institute of Neurology, Medical University of Vienna, Vienna, Austria., Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zadeh G; Division of Neurosurgery, Department of Surgery, University Health Network, Toronto, Ontario, Canada., Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., De Groot JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stead LF; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Verhaak RGW; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. roel.verhaak@jax.org.

Publikováno v: Nature [Nature] 2019 Dec; Vol. 576 (7785), pp. 112-120. Date of Electronic Publication: 2019 Nov 20.

Promoting Cardiovascular Health Worldwide: The Global Cardiovascular Nursing Leadership Forum.

Autor: Hayman LL; Laura L. Hayman, PhD, MSN, FAAN, FPCNA Associate Vice-Provost for Research & Graduate Studies and Professor of Nursing, University of Massachusetts Boston. Kathy Berra, MSN, NP-BC, FAANP, FAAN, FPCNA Co-Director, The LifeCare Company, Menlo Park, and Nurse Practitioner, Cardiovascular Medicine and Coronary Interventions, Redwood City, California. Barbara Fletcher, MN, RN, FAAN, FPCNA Clinical Associate Professor, Brooks College of Nursing, University of North Florida, Jacksonville. Nancy Houston Miller, BSN, FAHA, FPCNA Co-Director, The LifeCare Company, Menlo Park, California. Cheryl Dennison Himmelfarb, PhD, RN, ANP, FAAN, FPCNA Professor, Johns Hopkins Schools of Nursing, Medicine and Public Health; Director, Office for Science and Innovation; and Deputy Director, Institute for Clinical Translational Research, Baltimore, Maryland., Berra K, Fletcher B, Miller NH, Himmelfarb CD

Publikováno v: The Journal of cardiovascular nursing [J Cardiovasc Nurs] 2017 Sep/Oct; Vol. 32 (5), pp. 426-427.

Master regulators of FGFR2 signalling and breast cancer risk.

Autor: Fletcher MN; 1] Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] [4]., Castro MA, Wang X, de Santiago I, O'Reilly M, Chin SF, Rueda OM, Caldas C, Ponder BA, Markowetz F, Meyer KB

Publikováno v: Nature communications [Nat Commun] 2013; Vol. 4, pp. 2464.

Effect of para-substituents and solvent polarity on the formation of triphenylboroxine.amine adducts.

Autor: Kua J; Department of Chemistry, University of San Diego, 5998 Alcala Park, San Diego, CA 92110, USA. jkua@sandiego.edu, Fletcher MN, Iovine PM

Publikováno v: The journal of physical chemistry. A [J Phys Chem A] 2006 Jul 06; Vol. 110 (26), pp. 8158-66.